210 related articles for article (PubMed ID: 37091588)
1. Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model.
Ye S; Theotokis P; Lee JY; Kim MJ; Nheu D; Ellen O; Bedford T; Ramanujam P; Wright DK; McDonald SJ; Alrehaili A; Bakhuraysah M; Kang JH; Siatskas C; Tremblay CS; Curtis DJ; Grigoriadis N; Monif M; Strittmatter SM; Petratos S
Brain Commun; 2023; 5(2):fcad108. PubMed ID: 37091588
[TBL] [Abstract][Full Text] [Related]
2. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
3. Nogo receptor expression in microglia/macrophages during experimental autoimmune encephalomyelitis progression.
Alrehaili AA; Lee JY; Bakhuraysah MM; Kim MJ; Aui PM; Magee KA; Petratos S
Neural Regen Res; 2018 May; 13(5):896-907. PubMed ID: 29863021
[TBL] [Abstract][Full Text] [Related]
4. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.
Lee JY; Kim MJ; Thomas S; Oorschot V; Ramm G; Aui PM; Sekine Y; Deliyanti D; Wilkinson-Berka J; Niego B; Harvey AR; Theotokis P; McLean C; Strittmatter SM; Petratos S
J Neurosci; 2019 Jul; 39(28):5562-5580. PubMed ID: 31061088
[TBL] [Abstract][Full Text] [Related]
5. Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology.
Ineichen BV; Kapitza S; Bleul C; Good N; Plattner PS; Seyedsadr MS; Kaiser J; Schneider MP; Zörner B; Martin R; Linnebank M; Schwab ME
Acta Neuropathol; 2017 Sep; 134(3):423-440. PubMed ID: 28646336
[TBL] [Abstract][Full Text] [Related]
6. LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.
Li X; Zhang Y; Yan Y; Ciric B; Ma CG; Chin J; Curtis M; Rostami A; Zhang GX
Mol Neurobiol; 2017 Aug; 54(6):4365-4378. PubMed ID: 27344330
[TBL] [Abstract][Full Text] [Related]
7. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
[TBL] [Abstract][Full Text] [Related]
8. How does Nogo-A signalling influence mitochondrial function during multiple sclerosis pathogenesis?
Nheu D; Petratos S
Neurosci Biobehav Rev; 2024 Jun; ():105767. PubMed ID: 38885889
[TBL] [Abstract][Full Text] [Related]
9. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination.
Karnezis T; Mandemakers W; McQualter JL; Zheng B; Ho PP; Jordan KA; Murray BM; Barres B; Tessier-Lavigne M; Bernard CC
Nat Neurosci; 2004 Jul; 7(7):736-44. PubMed ID: 15184901
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis.
Seyedsadr MS; Weinmann O; Amorim A; Ineichen BV; Egger M; Mirnajafi-Zadeh J; Becher B; Javan M; Schwab ME
Neurobiol Dis; 2019 Apr; 124():189-201. PubMed ID: 30468865
[TBL] [Abstract][Full Text] [Related]
11. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
[TBL] [Abstract][Full Text] [Related]
12. Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.
Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Long ZY; Wu YM
Mol Neurobiol; 2015 Dec; 52(3):1821-1834. PubMed ID: 25394381
[TBL] [Abstract][Full Text] [Related]
13. Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
Kim MJ; Kang JH; Theotokis P; Grigoriadis N; Petratos S
Cells; 2018 Dec; 8(1):. PubMed ID: 30577457
[TBL] [Abstract][Full Text] [Related]
14. How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
Rashidbenam Z; Ozturk E; Pagnin M; Theotokis P; Grigoriadis N; Petratos S
Front Cell Neurosci; 2023; 17():1197492. PubMed ID: 37361998
[TBL] [Abstract][Full Text] [Related]
15. Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis.
Steinbach K; McDonald CL; Reindl M; Schweigreiter R; Bandtlow C; Martin R
PLoS One; 2011; 6(11):e26341. PubMed ID: 22096481
[TBL] [Abstract][Full Text] [Related]
16. Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitis.
Fontoura P; Ho PP; DeVoss J; Zheng B; Lee BJ; Kidd BA; Garren H; Sobel RA; Robinson WH; Tessier-Lavigne M; Steinman L
J Immunol; 2004 Dec; 173(11):6981-92. PubMed ID: 15557195
[TBL] [Abstract][Full Text] [Related]
17. Research on the mechanism of Zuogui Pill and Yougui Pill in promoting axonal regeneration in model rats of autoimmune encephalomyelitis.
Wang L; Zhao H; Fan YP; Gong HY; Li M; Qi F; Liu Y
Chin J Integr Med; 2010 Apr; 16(2):167-72. PubMed ID: 20473744
[TBL] [Abstract][Full Text] [Related]
18. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis.
Abdul-Majid KB; Stefferl A; Bourquin C; Lassmann H; Linington C; Olsson T; Kleinau S; Harris RA
Scand J Immunol; 2002 Jan; 55(1):70-81. PubMed ID: 11841694
[TBL] [Abstract][Full Text] [Related]
19. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
[TBL] [Abstract][Full Text] [Related]
20. Silencing Nogo-A promotes functional recovery in demyelinating disease.
Yang Y; Liu Y; Wei P; Peng H; Winger R; Hussain RZ; Ben LH; Cravens PD; Gocke AR; Puttaparthi K; Racke MK; McTigue DM; Lovett-Racke AE
Ann Neurol; 2010 Apr; 67(4):498-507. PubMed ID: 20437585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
